This is in line with the fact that p53 mutations often occur heterozygously with one wt TP53 allele in different human cancers (Supplementary Figure S1), suggesting that the p53LCs could dominantly negate the function of wt p53 in the tumors. The gene discussed is TP53; the disease is cancer.